Stasys Medical Corp. — Form D
Stasys Medical Corp. of KIRKLAND, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-07. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-06-07
- Form: D
- Accession: 0001632952-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.3M
- Remaining: $747K
- Investors: 3
- Date of first sale: 2017-05-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-288207
Issuer
- Name: Stasys Medical Corp.
- CIK: 0001632952
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 13608 88TH PL NE, KIRKLAND, WA, 980334
- Phone: (425) 591-7943
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Robert Barry | Director | Kirkland, WA |
| Mark Dye | Director | Kirkland, WA |
| Chris Igielski | Director | Seattle, WA |
| Michael Rackley | Director | Kirkland, WA |
| Linden Rhoads | Director | Seattle, WA |
| Nathan Sniadecki | Director | Kirkland, WA |
| Michael Rackley | Executive Officer | Kirkland, WA |
| Robert Barry | Promoter | Kirkland, WA |
| Nathan Sniadecki | Promoter | Kirkland, WA |
| Nathan White | Promoter | San Diego, CA |
| Nathan White | Director | San Diego, CA |
| Robert Barry | Executive Officer | Kirkland, WA |
Other filings by this issuer (1)
More